A phase I clinical evaluation of 1-(2-chloroethyl)-3-[2-(dimethylaminosulphonyl)ethyl]-1-nitrosourea (TCNU)
- 30 November 1987
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 23 (12) , 1837-1843
- https://doi.org/10.1016/0277-5379(87)90049-6
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- Modulation by Taurine of the Toxicity of Taumustine, a Compound With Antitumor Activity2JNCI Journal of the National Cancer Institute, 1985
- 1-(2-Chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU, NSC-79037): A comparison of drug administration at four-week and six-week intervalsPublished by Elsevier ,1973
- CLINICAL TRIALS WITH 1,3-BIS(2-CHLOROETHYL)-1-NITROSOUREA NSC-4099621965